Evidence map›Paper›PMID 42113898›Full record

ArticleAmerican journal of respiratory cell and molecular biology2026

Beyond slowing decline: leveraging apoptotic synergy to reverse pulmonary fibrosis.

Yohannes A Mebratu, Jeffrey C Horowitz

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Yohannes A MebratuDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine and The Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, United States.
Jeffrey C HorowitzDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine and The Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, United States.

Funding

The role of Bik in the replication and severity of influenza A virusR01AI148180 · NIAID · OHIO STATE UNIVERSITY · PI MEBRATU, YOHANNES AFEWORK · 2021 to 2025
$2.1M
Hypoxia-induced aberrant lactate generation and shuttling serves as a direct signal to promote pro-fibrotic fibroblast phenotypesR01HL171164 · NHLBI · OHIO STATE UNIVERSITY · PI Jeffrey C Horowitz, Richard S. Nho · 2025 to 2026
$1.5M
The Role of Ariadne RBR E3 ubiquitin protein ligase 2 (ARIH2) in influenza A virus replication and pathogenesis in the airway epithelial cellsR01AI187330 · NIAID · OHIO STATE UNIVERSITY · PI Yohannes Afework Mebratu · 2025 to 2026
$1.1M
NHLBI NIH HHS R01 HL171164NIAID NIH HHS R01 AI148180NIAID NIH HHS R01 AI187330NIH HHS R01AI148180NIH HHS R01AI187330NIH HHS R01HL171164
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42113898
PMCPMC13424674

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.